NAPROXEN/ESOMEPRAZOL ABDI

Medicinal product

(Invented) name

NAPROXEN/ESOMEPRAZOL ABDI

Active substance (s)

Naproksenas/Ezomeprazolas

Strength

500 mg/20 mg

Pharmaceutical form

modifikuoto atpalaidavimo tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

M01AE52, Naproxen and esomeprazole

Marketing authorisation holder

UAB Niromed, Lietuva

Date of authorisation

2026-05-13

Date of renewal

Documents

3381_NAPROXEN_ESOMEPRAZOL ABDI 500-20mg_tab_PZ_2026-05-13.docx

3381_NAPROXEN_ESOMEPRAZOL ABDI 500-20mg_tab_PL_2026-05-13.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Naproksenas	500 mg
Ezomeprazolas	20 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
120825	106933	1106933	buteliukas	N30		Receptinis	LT/L/26/3381/001	Netiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2026-05-13	Registruotas